BRCA2 Mutation Indicates Shorter Survival in Men with Prostate Cancer
A study performed in the UK, reported in the British Journal Cancer (2010), showed that men who have a deleterious germ-line mutation in the breast cancer 2 (BRCA2) gene and who have prostate cancer do [...]
Advanced Prostate Cancer Teleconference Is Available On-Line
The recent teleconference I had with Dr. James Mckiernan about advanced prostate cancer is now available to listen to on-line. Many people have been asking how to hear the conference, now you can. Go to [...]
Presidential Proclamation–National Prostate Cancer Awareness Month
President Obama finally declares September as National Prostate Cancer Month A PROCLAMATION Although its mortality rate has steadily fallen in the last decade, prostate cancer is still the second leading cause of cancer deaths among [...]
Finally, CMS Announces A Meeting to Discuss Medicare Coverage for Provenge
The Center for Medicare and Medicaid Services (CMS), the U.S. agency in charge of Medicare, announced yesterday that it has scheduled a meeting to discuss the coverage of Dendreon’s prostate cancer vaccine Provenge. The meeting [...]
Pamidronate or Zoledronic Acid – Is There A Difference In the End Results?
Pamidronate and zoledronic acid (bisphosphonates) are a mainstay in the treatment of men with advanced prostate cancer as well as for breast cancer survivors for the prevention of skeletal-related events (SREs). There have been many [...]
Managing Other Side Effects From Taxotere – Part III
Besides the blood problems and the gastric problems I discussed in the last two posts, taxotere can also cause hair loss and have effects on your skin and nails. The q3wk dose of taxotere (higher [...]